Abstract
A preemptive multi-hop contact tracing scheme that tracks not only the direct contacts of those who tested positive for COVID-19, but also secondary or tertiary contacts has been proposed and deployed in practice with some success. We propose a mathematical methodology for evaluating this preemptive contact tracing strategy that combines the contact tracing dynamics and the virus transmission mechanism in a single framework using microscopic Markov Chain approach (MMCA). We perform Monte Carlo (MC) simulations to validate our model and show that the output of our model provides a reasonable match with the result of MC simulations. Utilizing the formulation under a human contact network generated from real-world data, we show that the cost-benefit tradeoff can be significantly enhanced through an implementation of the multi-hop contact tracing as compared to traditional contact tracing. We further shed light on the mechanisms behind the effectiveness of the multi-hop testing strategy using the framework. We show that our mathematical framework allows significantly faster computation of key attributes for multi-hop contact tracing as compared to MC simulations. This in turn enables the investigation of these attributes for large contact networks, and constitutes a significant strength of our approach as the contact networks that arise in practice are typically large.
Funder
National Science Foundation
Publisher
Public Library of Science (PLoS)
Reference22 articles.
1. Presymptomatic Transmission of SARS-CoV-2—Singapore, January 23–March 16, 2020;WE Wei;Morbidity and Mortality Weekly Report,2020
2. Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts;Q Bi;MedRxiv,2020
3. Using a real-world network to model localized COVID-19 control strategies;JA Firth;Nature medicine,2020
4. Tracing and testing multiple generations of contacts to COVID-19 cases: cost–benefit trade-offs;J Kim;Royal Society Open Science,2022
5. The first 100 days of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) control in Vietnam;PQ Thai;Clinical infectious diseases,2021